In the latest trading session, 0.83 million Timber Pharmaceuticals Inc (AMEX:TMBR) shares changed hands as the company’s beta touched -0.13. With the company’s most recent per share price at $0.46 changed hands at -$1.0 or -68.63% at last look, the market valuation stands at $1.57M. TMBR’s current price is a discount, trading about -636.96% off its 52-week high of $3.39. The share price had its 52-week low at $1.20, which suggests the last value was -160.87% down since then. When we look at Timber Pharmaceuticals Inc’s average trading volume, we note the 10-day average is 72920.0 shares, with the 3-month average coming to 367.66K.
Timber Pharmaceuticals Inc (AMEX:TMBR) trade information
Instantly TMBR was in red as seen in intraday trades today. With action -81.06%, the performance over the past five days has been red. The drop to weekly highs of 2.4900 on Friday, 11/17/23 subtracted -68.63% to the stock’s daily price. The company’s shares are showing year-to-date downside of -73.81%, with the 5-day performance at -81.06% in the red. However, in the 30-day time frame, Timber Pharmaceuticals Inc (AMEX:TMBR) is -83.75% down. Looking at the short shares, we see there were 9680.0 shares sold at short interest cover period of 0.27 days.
Elon Musk just Triggered a BOOM in These Stocks
Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"
Click Here to Download the FREE Report.
Sponsored
Timber Pharmaceuticals Inc (TMBR) estimates and forecasts
Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2023 revenue estimates. The rating firms predict current quarter revenue for Timber Pharmaceuticals Inc will rise 49.60%, while the growth in revenue is estimated to hit 82.70% for the next quarter.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 74.04%.
TMBR Dividends
Timber Pharmaceuticals Inc is expected to release its next quarterly earnings report between November 21 and November 26.
Timber Pharmaceuticals Inc (AMEX:TMBR)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 1.11% of Timber Pharmaceuticals Inc shares while 7.79% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.87%. There are 7.79% institutions holding the Timber Pharmaceuticals Inc stock share, with Vanguard Group Inc the top institutional holder. As of Jun 29, 2023, the company held 1.13% of the shares, roughly 38687.0 TMBR shares worth $94009.0.
Citadel Advisors Llc holds the second largest percentage of outstanding shares, with 0.97% or 33185.0 shares worth $80639.0 as of Jun 29, 2023.
Among Mutual Funds, the top two as of Jun 29, 2023 were Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. With 38687.0 shares estimated at $94009.0 under it, the former controlled 1.13% of total outstanding shares. On the other hand, Fidelity Extended Market Index Fund held about 0.41% of the shares, roughly 13966.0 shares worth around $20250.0.
